Delivery Order SPE2DB20D2014-SPE2DB25FD04Q
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $17,962.22 on August 4, 2025, for the supply of Entresto 24 mg-26 mg tablets (180-count). This competitively awarded, firm fixed-price delivery order is non-set-aside and will be performed at the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 5, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $14,209.93 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Entresto 49 mg-51 mg tablets (60-count packaging). The contract, with an ultimate completion date of August 19, 2025, represents a non-set-aside competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a ceiling value of $999,999,999.00 and runs through December...
- The Defense Logistics Agency awarded a $9,378.51 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Entresto 24 mg-26 mg tablets (180-count). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 17, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $9,308 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Entresto 49 mg-51 mg tablets (180-count supply) on September 10, 2025, with an ultimate completion date of September 11, 2025. The contract is not set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency (DLA) awarded a $32,989.70 delivery order to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180-count units) on August 25, 2025, with an ultimate completion date of August 26, 2025. This non-set-aside, firm fixed-price contract was awarded through open competition and reflects AmerisourceBergen's established role as a critical pharmaceutical distributor within the federal medical supply chain. The delivery order is being performed at...
- The Defense Logistics Agency awarded a delivery order valued at approximately $29,471 to AmerisourceBergen Drug Corp for the supply of Entresto 97 mg-103 mg tablets (60-count units) on August 13, 2025, with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on March 18, 2025, for the supply of Entresto 24 mg-26 mg tablets (180-unit quantity) valued at $1,476.42. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement across military and veteran healthcare...
- The Defense Logistics Agency awarded a $6,279.78 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Entresto 49 mg-51 mg tablets (180-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of August 25, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $25,090.47 on May 2, 2025, for the supply of Entresto 24 mg-26 mg tablets (60-count units). This firm fixed-price, competitively awarded contract is non-set-aside and will be performed at the awardee's Conshohocken, Pennsylvania location, with an ultimate completion date of May 5, 2025. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $3,689.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Entresto 24 mg-26 mg tablets (60-count supply) on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-competitive delivery order was placed against AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be fulfilled at...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FD04QDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,979.12 on September 18, 2025, for the supply of Entresto 24 mg-26 mg tablets (60-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies a broad range of medications and medical supplies to military and veteran healthcare systems through the Defense Logistics Agency. The company's significant IDC vehicle enables it to deliver specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. This particular delivery order for Entresto, a heart failure medication, reflects the company's ongoing role in fulfilling federal pharmaceutical needs through competitively awarded contracts with firm fixed pricing.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 9/18/25 |